台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    79.1
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    32
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-永豐金-萬盛 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/037577.58082.58587.5May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

永豐金-萬盛 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/0100.000.178.6079.10-0.1205-0.04%
2025/03/26083.7500.0083.4002030.00%
2025/03/24083.4000.0083.5002070.00%
2025/03/18083.9000.0083.9001970.00%
2025/03/17084.6000.0084.2001970.00%
2025/03/120.182.8000.0084.500.12010.05%
2025/03/11182.0000.0084.2012030.49%
2025/03/060.184.2000.0085.100.12030.04%
2025/02/26085.7000.0085.7002200.00%
2025/02/2500.000.185.3085.70-0.1232-0.06%
2025/02/21185.5000.0086.0012360.42%
2025/02/20286.1400.0085.8022330.87%
2025/02/19886.530.186.0086.007.92323.40%
2025/02/1800.001086.1886.00-10229-4.35%
2025/02/14384.6300.0084.6032211.36%
2025/02/12784.6700.0083.5072173.22%
2025/02/11083.4100.0084.2002160.01%
2025/01/09176.6000.0076.8011920.52%
2025/01/080.177.0000.0077.800.11910.05%
2024/12/2700.00177.6077.70-1185-0.54%
2024/12/24075.9000.0076.0001730.01%
2024/12/230.176.3000.0076.200.11720.03%
2024/12/180.174.50173.9075.90-0.9171-0.53%
2024/12/17973.4400.0073.8091665.40%
2024/12/161473.0300.0072.90141648.49%
2024/12/110.174.0000.0073.800.11580.04%
2024/12/10173.4000.0073.4011560.64%
2024/12/09275.65175.6075.4011490.67%
2024/11/27079.0000.0078.3001260.02%
2024/11/2500.002780.2180.30-27128-20.98%
2024/11/2200.001679.4082.00-16121-13.12%
2024/10/301077.6000.0077.90101228.20%
2024/10/2900.00078.5077.8001230.00%
2024/10/09080.5000.0080.7001580.00%
2024/10/07182.0000.0082.3011640.61%
2024/09/30082.0000.0082.5001810.00%
2024/09/26082.0000.0081.9001870.00%
2024/08/3000.00181.7081.70-1290-0.34%
2024/08/14177.8000.0078.4012950.34%
2024/08/053371.7000.0072.503329911.00%
2024/08/02080.9000.0079.5002910.00%
2024/07/2300.00382.3082.10-3287-1.04%
2024/07/1900.000.482.6082.60-0.4283-0.13%
2024/07/150.183.20383.7083.40-3284-1.04%
2024/07/11184.4000.0083.4012800.36%
2024/06/26184.0000.0084.3012660.38%
2024/06/25181.2000.0083.5012600.38%
2024/06/24196.4000.0089.2012380.42%
2024/06/19197.8000.0098.0012240.45%
2024/06/110.397.0000.0097.400.32230.13%
2024/06/0700.000.499.0299.60-0.4220-0.18%
2024/06/06196.3000.0095.8012070.48%
2024/06/0300.00194.8094.70-1223-0.45%
2024/05/06194.3000.0094.6013180.31%
2024/05/02195.9000.0096.0013190.31%
2024/04/2600.000.196.0095.00-0.1318-0.03%
2024/04/2200.00293.7094.00-2331-0.60%
2024/04/19195.6000.0093.6013390.30%
2024/04/1700.00196.8097.00-1331-0.30%
2024/04/16098.3000.0096.8003340.00%
2024/04/08199.4000.0099.6013290.30%
逸達兒童中樞性早熟三期臨床 三度獲DSMB正面回饋持續進行Anue鉅亨-2025/02/17
逸達受美國經銷商指示不定期出貨 1月營收年減逾6成Anue鉅亨-2025/02/08
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-2025/01/14
逸達 相關文章
逸達 相關影音
 
 
33小時17